These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11719217)

  • 41. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.
    Baskaran R; Wood LD; Whitaker LL; Canman CE; Morgan SE; Xu Y; Barlow C; Baltimore D; Wynshaw-Boris A; Kastan MB; Wang JY
    Nature; 1997 May; 387(6632):516-9. PubMed ID: 9168116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1.
    Kharbanda S; Bharti A; Pei D; Wang J; Pandey P; Ren R; Weichselbaum R; Walsh CT; Kufe D
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6898-901. PubMed ID: 8692915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A myristoyl/phosphotyrosine switch regulates c-Abl.
    Hantschel O; Nagar B; Guettler S; Kretzschmar J; Dorey K; Kuriyan J; Superti-Furga G
    Cell; 2003 Mar; 112(6):845-57. PubMed ID: 12654250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
    Lin HK; Wang L; Hu YC; Altuwaijri S; Chang C
    EMBO J; 2002 Aug; 21(15):4037-48. PubMed ID: 12145204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. E1AF degradation by a ubiquitin-proteasome pathway.
    Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kobayashi M; Totsuka Y; Kohgo T; Shindoh M
    Biochem Biophys Res Commun; 2005 Feb; 327(2):575-80. PubMed ID: 15629152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
    Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    Barilá D; Mangano R; Gonfloni S; Kretzschmar J; Moro M; Bohmann D; Superti-Furga G
    EMBO J; 2000 Jan; 19(2):273-81. PubMed ID: 10637231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional interaction between DNA-PK and c-Abl in response to DNA damage.
    Kharbanda S; Pandey P; Jin S; Inoue S; Bharti A; Yuan ZM; Weichselbaum R; Weaver D; Kufe D
    Nature; 1997 Apr; 386(6626):732-5. PubMed ID: 9109492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.
    Soubeyran P; Barac A; Szymkiewicz I; Dikic I
    Biochem J; 2003 Feb; 370(Pt 1):29-34. PubMed ID: 12475393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization.
    Smith KM; Van Etten RA
    J Biol Chem; 2001 Jun; 276(26):24372-9. PubMed ID: 11320088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel C-terminal proteolytic processing of cytosolic pyruvate kinase, its phosphorylation and degradation by the proteasome in developing soybean seeds.
    Tang GQ; Hardin SC; Dewey R; Huber SC
    Plant J; 2003 Apr; 34(1):77-93. PubMed ID: 12662311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species.
    Sun X; Majumder P; Shioya H; Wu F; Kumar S; Weichselbaum R; Kharbanda S; Kufe D
    J Biol Chem; 2000 Jun; 275(23):17237-40. PubMed ID: 10770918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.
    Jackson P; Baltimore D; Picard D
    EMBO J; 1993 Jul; 12(7):2809-19. PubMed ID: 8334997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roles for c-Abl in postoperative neurodegeneration.
    Feng L; Fu S; Yao Y; Li Y; Xu L; Zhao Y; Luo L
    Int J Med Sci; 2022; 19(12):1753-1761. PubMed ID: 36313229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c‑Abl‑mediated tyrosine phosphorylation of DNA damage response proteins and implications in important cellular functions (Review).
    Bohio AA; Wang R; Zeng X; Ba X
    Mol Med Rep; 2020 Aug; 22(2):612-619. PubMed ID: 32468042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. c-Abl regulation: a tail of two lipids.
    Van Etten RA
    Curr Biol; 2003 Aug; 13(15):R608-10. PubMed ID: 12906815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts.
    Bradley WD; Koleske AJ
    J Cell Sci; 2009 Oct; 122(Pt 19):3441-54. PubMed ID: 19759284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Abl in neurodegenerative disease.
    Schlatterer SD; Acker CM; Davies P
    J Mol Neurosci; 2011 Nov; 45(3):445-52. PubMed ID: 21728062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assays for tyrosine phosphorylation in human cells.
    Kruk M; Widstrom N; Jena S; Wolter NL; Blankenhorn JF; Abdalla I; Yang TY; Parker LL
    Methods Enzymol; 2019; 626():375-406. PubMed ID: 31606083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T cell survival and function requires the c-Abl tyrosine kinase.
    Silberman I; Sionov RV; Zuckerman V; Haupt S; Goldberg Z; Strasser A; Ben-Sasson ZS; Baniyash M; Koleske AJ; Haupt Y
    Cell Cycle; 2008 Dec; 7(24):3847-57. PubMed ID: 19098427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.